Search Results

There are 41977 results for: content related to: A 24-week course of high-dose interferon-α plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels

  1. Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?

    Journal of Viral Hepatitis

    Volume 17, Issue 1, January 2010, Pages: 51–58, A. Lawson and on behalf of the Trent Hepatitis C Study Group

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1365-2893.2009.01148.x

  2. You have free access to this content
    Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

    Hepatology

    Volume 26, Issue 6, December 1997, Pages: 1393–1398, C Puoti, A Magrini, T Stati, P Rigato, F Montagnese, P Rossi, L Aldegheri and S Resta

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510260603

  3. You have free access to this content
    Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels

    Hepatology

    Volume 40, Issue 6, December 2004, Pages: 1442–1449, Bernd Kronenberger, Eva Herrmann, Florence Micol, Michael von Wagner and Stefan Zeuzem

    Version of Record online : 24 NOV 2004, DOI: 10.1002/hep.20487

  4. Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes

    Journal of Viral Hepatitis

    Volume 17, Issue 12, December 2010, Pages: 866–871, I. Maida, L. Martin-Carbonero, G. Sotgiu, E. Vispo, P. Barreiro, J. Gonzalez-Lahoz and V. Soriano

    Version of Record online : 10 NOV 2010, DOI: 10.1111/j.1365-2893.2009.01260.x

  5. You have free access to this content
    Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 6, March 2006, Pages: 777–785, E. J. BINI and S. MEHANDRU

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1365-2036.2006.02819.x

  6. You have free access to this content
    Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 8, October 2006, Pages: 1133–1149, S. ZEUZEM, A. ALBERTI, W. ROSENBERG, P. MARCELLIN, M. DIAGO, F. NEGRO, D. PRATI, C. PUOTI, S. K. ROBERTS and M. L. SHIFFMAN

    Version of Record online : 20 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03073.x

  7. You have free access to this content
    Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis

    HIV Medicine

    Volume 10, Issue 7, August 2009, Pages: 417–421, F Bani-Sadr, K Barange, F Daoud, C Jacomet, A Bicart-See, E Rosenthal, P Cacoub, S Pol, C Perronne, F Carrat and the ANRS HC02 – Ribavic Study Team

    Version of Record online : 26 MAR 2009, DOI: 10.1111/j.1468-1293.2009.00702.x

  8. Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels

    Journal of Viral Hepatitis

    Volume 20, Issue 5, May 2013, Pages: 328–335, X. Du, J. Wang, L. Shao, X. Hu, C. Yang, L. Shen, X. Weng and W. Zhang

    Version of Record online : 8 JAN 2013, DOI: 10.1111/jvh.12034

  9. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 12, Issue 3, May 2005, Pages: 307–314, B. Kronenberger, M. von Wagner, E. Herrmann, U. Mihm, A. Piiper, C. Sarrazin and S. Zeuzem

    Version of Record online : 4 MAR 2005, DOI: 10.1111/j.1365-2893.2005.00594.x

  10. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels

    Liver International

    Volume 26, Issue 6, August 2006, Pages: 643–649, Michael G. Bruce, Dana Bruden, Brian J. McMahon, Carol Christensen, Chriss Homan, Dan Sullivan, Heike Deubner, Thomas Hennessy, Jim Williams, Stephen Livingston and David Gretch

    Version of Record online : 11 MAY 2006, DOI: 10.1111/j.1478-3231.2006.01281.x

  11. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases

    Liver International

    Volume 26, Issue 9, November 2006, Pages: 1087–1094, Chen-Hua Liu, Jou-Wei Lin, Feng-Chiao Tsai, Pei-Ming Yang, Ming-Yang Lai, Jun-Herng Chen, Jia-Horng Kao and Ding-Shinn Chen

    Version of Record online : 21 SEP 2006, DOI: 10.1111/j.1478-3231.2006.01355.x

  12. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  13. You have free access to this content
    Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study

    Hepatology

    Volume 36, Issue 4, October 2002, Pages: 973–977, Pierre Pradat, Alfredo Alberti, Thierry Poynard, Juan-Ignacio Esteban, Ola Weiland, Patrick Marcellin, Salvatore Badalamenti and Christian Trépo

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.35530

  14. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years

    Journal of Viral Hepatitis

    Volume 13, Issue 5, May 2006, Pages: 290–296, M. Persico, S. Perrotta, E. Persico, L. Terracciano, A. Folgori, L. Ruggeri, A. Nicosia, R. Vecchione, V. L. Mura, M. Masarone and R. Torella

    Version of Record online : 29 SEP 2005, DOI: 10.1111/j.1365-2893.2005.00667.x

  15. You have free access to this content
    Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection?

    Hepatology

    Volume 48, Issue 5, November 2008, Pages: 1451–1459, George V. Papatheodoridis, Emanuel K. Manesis, Spilios Manolakopoulos, Ioannis S. Elefsiniotis, John Goulis, John Giannousis, Antonios Bilalis, Georgia Kafiri, Dimitrios Tzourmakliotis and Athanasios J. Archimandritis

    Version of Record online : 10 JUL 2008, DOI: 10.1002/hep.22518

  16. Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently ‘normal’ alanine aminotransferase levels treated with peginterferon α-2a (40KD) plus ribavirin

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 61–71, Eric Snoeck, Stephanos J. Hadziyannis, Claudio Puoti, Mark G. Swain, Thomas Berg, Patrick Marcellin, Jean-Pierre Zarski, Karin Jorga and Stefan Zeuzem

    Version of Record online : 26 OCT 2007, DOI: 10.1111/j.1478-3231.2007.01603.x

  17. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  18. Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α-2a (40 kDa) plus ribavirin: Impact on health-related quality of life

    Journal of Gastroenterology and Hepatology

    Volume 21, Issue 2, February 2006, Pages: 406–412, SANJEEV ARORA, CHRISTOPHER O'BRIEN, STEFAN ZEUZEM, MITCHELL L SHIFFMAN, MOISES DIAGO, ALBERT TRAN, PAUL J POCKROS, ROBERT W REINDOLLAR, EDWARD GANE, KAVITA PATEL, NEIL WINTFELD and JESSE GREEN

    Version of Record online : 22 NOV 2005, DOI: 10.1111/j.1440-1746.2005.04059.x

  19. You have free access to this content
    Viral clearance in HCV viraemic patients with normal alanine aminotransferase after combination therapy: a controlled, open-labelled study

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 3, February 2004, Pages: 331–337, A. Mangia, G. Spinzi, O. Vuturo, V. Pazienza, A. Iacobellis, M. Piattelli, A. Giacobbe, G. Leandro, V. Piermanni, G. Minoli, G. Montalto and A. Andriulli

    Version of Record online : 20 JAN 2004, DOI: 10.1111/j.1365-2036.2004.01844.x

  20. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040